Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Article in Radiotherapy and Oncology (February 2022)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Radiotherapy and Oncology (February 2022)
Article in Journal of radiosurgery and SBRT (January 2022)
Article in International Journal of Radiation Oncology • Biology • Physics (October 2021)